Marex Group’s stock got a sizable bump after the firm’s latest 13F filing revealed a roughly $9.4 million stake in two spot XRP ETFs — a disclosure that briefly put the Nasdaq-listed financial services firm among the larger institutional holders of XRP ETF shares in the U.S.
The details: Marex reported owning 356,865 shares of the Canary XRP ETF (about $5.1 million) and 286,021 shares of the Bitwise XRP ETF (about $4.3 million) as of Q1 2026. The Canary holding alone jumped 51% from the prior quarter (173,298 shares), signaling aggressive buying in a short period. Those moves helped push Marex’s stock higher: MEX shares closed up 4.2% at $58.25 on Wednesday, and the stock had risen more than 15% over the prior week and more than 50% year-to-date.
Context matters. Marex’s combined $9.4 million positions put it near the top of institutional XRP ETF holders, but it still trails much larger players — Goldman Sachs leads with roughly $152.16 million of exposure and Millennium Management holds over $27 million across spot XRP funds. What sets Marex apart is the pace of accumulation within a single quarter.
Marex’s filing also showed activity beyond XRP:
- It boosted its stake in Strategy (the company formerly known as MicroStrategy, ticker MSTR) from 2.9 million shares to 3.4 million.
- It trimmed its call option positions on Strategy from 108,100 to 65,500 contracts.
- It expanded holdings in Strategy’s perpetual preferred shares (STRK) from 4,400 to 16,401.
Strategy’s stock closed down 3.4% at $178.03 on Wednesday and eased another 0.2% in premarket trading Thursday. Marex also reduced exposure to other crypto-related names, including TON Strategy and Bitmine Immersion Technologies.
Market snapshot: XRP was trading around $1.43 at the time of the filing, with a 24‑hour range of $1.41–$1.47.
Why this matters: the 13F disclosure adds to a string of institutional filings showing Wall Street taking positions in spot XRP ETFs — a trend that proponents say reflects growing confidence in XRP’s role in markets. Ripple CEO Brad Garlinghouse has been vocal about XRP’s utility and the company’s expanding partnerships, and those developments appear to be drawing attention from large money managers. That said, quarterly filings show snapshots of activity; they don’t prove sustained buying across subsequent periods.
Bottom line: Marex’s brisk accumulation of XRP ETF shares is another sign of institutional interest in XRP-related products, even as the biggest exposures remain with blue-chip asset managers.
Read more AI-generated news on: undefined/news
